Moguilner, Sebastian
Herzog, Rubén
Perl, Yonatan Sanz
Medel, Vicente
Cruzat, Josefina
Coronel, Carlos
Kringelbach, Morten
Deco, Gustavo
Ibáñez, Agustín
Tagliazucchi, Enzo
Funding for this research was provided by:
Alzheimer’s Association (GBHI ALZ UK-21-721776, SG-20-725707-ReDLat)
Takeda (CW2680521)
FONCYT-PICT (2017-1818)
ANID/FONDECYT (Regular 1210195, Regular 1220995)
ANID/PIA/ANILLOS (ACT210096)
the National Institutes of Aging of the National Institutes of Health (R01AG057234)
Agencia I+D+i, Argentina (PICT2019–02294)
Article History
Received: 6 November 2023
Accepted: 2 April 2024
First Online: 11 April 2024
Declarations
:
: The IRB of the participating institutions that contributed MRI images to this analysis approved the study. All the participants of this study signed a consent form following the declaration of Helsinki.
: Not applicable.
: AI has received consultancy fees from Roche, Lilly, and Comulus. The other authors declare that they have no competing interests.